CORGENIX MEDICAL CORP/CO
company.status.inactiveCIK 1063665fmd_1YASSVBZSH8DAX2PPDD7M2F6FHManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jul 01, 2010 to Dec 31, 2014, 18 periods
Latest annual · FY2014
Millions- Total revenues
- 11
- Gross profit
- 5
- Operating income
- 0
- Net income
- 0
Latest quarter · Q2 FY2015
Millions- Total revenues
- 4
- Gross profit
- 2
- Operating income
- 0
- Net income
- 0
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- +11.5%
CORGENIX MEDICAL CORP/CO financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $11 million | $10.2 million | +8.1% | 10-K 2014-09-10 · proof |
| Gross profit | $5.3 million | $4.6 million | +15.9% | 10-K 2014-09-10 · proof |
| Operating income | $399,601 | $296,385 | +34.8% | 10-K 2014-09-10 · proof |
| Net income | $371,437 | $278,536 | +33.4% | 10-K 2014-09-10 · proof |
| Cash from operating activities | $568,772 | $501,024 | +13.5% | 10-K 2014-09-10 · proof |
| Total assets | $7.8 million | $6.7 million | +15.7% | 10-K 2014-09-10 · proof |
| Total liabilities | $1.6 million | $1.3 million | +21.1% | 10-K 2014-09-10 · proof |
| Cash and cash equivalents | $2.4 million | $2 million | +24.7% | 10-K 2014-09-10 · proof |
- What was CORGENIX MEDICAL CORP/CO's revenue in fiscal 2014?
- CORGENIX MEDICAL CORP/CO reported revenue of $11 million for fiscal 2014 (the year ended Jun 30, 2014), against $10.2 million the year before (+8.1%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What was CORGENIX MEDICAL CORP/CO's gross profit in fiscal 2014?
- CORGENIX MEDICAL CORP/CO reported gross profit of $5.3 million for fiscal 2014 (the year ended Jun 30, 2014), against $4.6 million the year before (+15.9%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What was CORGENIX MEDICAL CORP/CO's operating income in fiscal 2014?
- CORGENIX MEDICAL CORP/CO reported operating income of $399,601 for fiscal 2014 (the year ended Jun 30, 2014), against $296,385 the year before (+34.8%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What was CORGENIX MEDICAL CORP/CO's net income in fiscal 2014?
- CORGENIX MEDICAL CORP/CO reported net income of $371,437 for fiscal 2014 (the year ended Jun 30, 2014), against $278,536 the year before (+33.4%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What was CORGENIX MEDICAL CORP/CO's cash from operating activities in fiscal 2014?
- CORGENIX MEDICAL CORP/CO reported cash from operating activities of $568,772 for fiscal 2014 (the year ended Jun 30, 2014), against $501,024 the year before (+13.5%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What are CORGENIX MEDICAL CORP/CO's total assets?
- As of Jun 30, 2014, CORGENIX MEDICAL CORP/CO reported total assets of $7.8 million, against $6.7 million a year earlier (+15.7%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What are CORGENIX MEDICAL CORP/CO's total liabilities?
- As of Jun 30, 2014, CORGENIX MEDICAL CORP/CO reported total liabilities of $1.6 million, against $1.3 million a year earlier (+21.1%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
- What are CORGENIX MEDICAL CORP/CO's cash and cash equivalents?
- As of Jun 30, 2014, CORGENIX MEDICAL CORP/CO reported cash and cash equivalents of $2.4 million, against $2 million a year earlier (+24.7%). Source: the 10-K filed with the SEC on Sep 10, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1063665&period_type=annual&limit=5"Information only, not investment advice.